Results 121 to 130 of about 68,105 (186)

Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant Escherichia coli using a hollow fiber infection model: a proof-of-concept study

open access: yesAntimicrobial Agents and Chemotherapy
Carbapenems, often regarded as the last line of defense in treatment of urinary tract infections and urosepsis caused by Escherichia coli, are under pressure from emerging resistance.
Mikaela M. Walker   +8 more
doaj   +1 more source

Reply to Letter to the Editor on Beyond Prophylaxis: Antimicrobial Stewardship for Bacterial Infections in Cirrhosis

open access: yes
United European Gastroenterology Journal, Volume 14, Issue 9, November 2026.
Solaiman Ezzafzafi   +2 more
wiley   +1 more source

Ceftazidime and cefotaxime--the clinician's choice.

open access: yes, 1989
A review of two third-generation cephalosporins, ceftazidime and cefotaxime, is presented. Ceftazidime, often used as a single agent, has shown greater activity than cefotaxime against Pseudomonas aeruginosa and other Pseudomonas species ...
Puthucheary, S.D., Goldsworthy, P.J.
core  

Ceftazidime-resistance in pediatric melioidosis: A case report and literature review

open access: yes
We report a first case of ceftazidime-resistant pediatric melioidosis involving a previously healthy seven-year-old boy who presented with right lobar pneumonia complicated with a 5-cm lung abscess.
Charles Dekun Lai   +9 more
core   +1 more source

Assessment of the Appropriateness of Ceftazidime Use in a Tertiary Teaching Hospital, Northern Ethiopia

open access: yesDrug, Healthcare and Patient Safety, 2019
Teklu Gebrehiwot Gebremichael,1 Hiluf Hindeya Gebreyesus,2 Alem Gebremariam1 1Clinical Pharmacy Unit, School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia; 2Medical Physiology Unit, Biomedical Division, School of ...
Gebremichael TG   +2 more
doaj  

Enhanced antibacterial activity of ceftazidime against pseudomonas aeruginosa using poly (propyleneimine) dendrimer as a nanocarrier

open access: yes, 2015
The aim of the current study is the loading of ceftazidime into the first generation of poly(propyleneimine) dendrimer (PPI-G1) to produce an effective drug delivery system against Pseudomonas aeruginosa.
Aghayari, M.   +6 more
core  

Emergence of KPC-8-producing K. pneumoniae infection without prior exposure to ceftazidime/avibactam: the threat of de novo infections by ceftazidime/avibactam-resistant KPC variants

open access: yes
De novo infections caused by ceftazidime/avibactam-resistant KPC variants are rarely reported. We characterize the evolution of a KPC-8-producing Klebsiella pneumoniae strain involved in a primary infection without previous ceftazidime/avibactam ...
Mateo-Vargas, María Alejandra   +5 more
core   +1 more source

Cefditoren versus ceftazidime in inducer-substrate combinations for the evaluation of AmpC production in a disc approximation test

open access: yes, 2010
Objective: To evaluate cefditoren in inducer-substrate combinations to screen for AmpC induction. Methods: 100 clinical isolates (25 P. aeruginosa, 25 E. cloacae, 14 M. morganii, 13 S. marcescens, 12 C. freundii, 7 P. rettgeri, and 4 E.
Coronel, Pilar   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy